Dermata Therapeutics, Inc. - DRMA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2025 · Q1 2025
Value (USD)
Total reported value ($000)
$295K
QoQ value delta ($000)
-$263K (-47.13%)
Implied price effect (QoQ)
-46.05%
Shares
Total shares
508,154
QoQ shares delta
-10,359 (-2.0%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (DRMA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2025)

Top 25 only Full list
Early Q2 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 188 322,179 0.0%
UBS Group AG 53 90,955 0.0%
XTX Topco Ltd 20 34,492 0.0%
GEODE CAPITAL MANAGEMENT, LLC 16 27,385 0.0%
TWO SIGMA SECURITIES, LLC 8 14,724 0.0%
JONES FINANCIAL COMPANIES LLLP 7 12,000 0.0%
Tower Research Capital LLC (TRC) 3 5,318 0.0%
BANK OF AMERICA CORP /DE/ 0 31 0.0%
CITIGROUP INC 0 60 0.0%
SBI Securities Co., Ltd. 0 1,010 0.0%